Sperm associated antigen 9 (SPAG9), as a novel member of the CT antigen family, was first identified from a human testis cDNA library in 1998 [46], and later found to be aberrantly activated and highly expressed in numerous types of human cancer. Here, SPAG9 is linked to cancer.